Association of a common variant of the CASP8 gene with reduced risk of breast cancer

Journal of the National Cancer Institute

Volumn 96, Issue 24, 2004, Pages 1866-1869

  MacPherson, Gordon ^a   Healey, Catherine S ^b   Teare, M Dawn ^a   Balasubramanian, Sabapathy P ^a   Reed, Malcolm W R ^a   Pharoah, Paul D P ^b   Ponder, Bruce A J ^b   Meuth, Mark ^a   Bhattacharyya, Nitai P ^c   Cox, Angela ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c SAHA INSTITUTE OF NUCLEAR PHYSICS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 10; CASPASE 8; DEATH RECEPTOR 4;

ADULT; AGED; ALLELE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HERITABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PENETRANCE; PRIORITY JOURNAL; REPRODUCIBILITY; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

ASPARTIC ACID; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CASPASE 10; CASPASE 8; CASPASES; ENGLAND; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HISTIDINE; HOMOZYGOTE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TUMOR NECROSIS FACTOR; VARIATION (GENETICS);

EID: 19944427300     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/dji001     Document Type: Article

References (20)

1. Easton DF. How many more breast cancer predisposition genes are there? Breast Cancer Res 1999;1:14-7.
2. Pharoah P, Antoniou A, Bobrow M, Zimmern RL, Easton D, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002;31: 33-6.
3. Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, Lipscombe JM, et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 2002;11:1399-407.
4. Rafii S, O'Regan P, Xinarianos G, Azmy I, Stephenson T, Reed M, et al. A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer. Hum Mol Genet 2002;12:1433-8.
5. Healey CS, Dunning AM, Teare MD, Parker L, Burn J, Chang-Claude J, et al. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet 2000;26:362-5.
6. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411:342-8.
7. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-6.
8. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65.
9. Shin M, Kim H, Lee S, Park J, Lee J, Jung S. Mutation of tumour necrosis factor related apoptosis-inducing ligand receptor (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers. Cancer Res 2001;61: 4942-6.
10. Anglian Breast Cancer Study Group. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer case patients. Br J Cancer 2000;83:10301-8.
11. Day N, Oakes S, Luben R, Khaw K, Bingham S, Welch A, et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 1999;80(Suppl 1):95-103.
12. Fisher MJ, Virmani AK, Wu L, Aplenc R, Harper JC, Powell SM, et al. Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer. Clin Cancer Res 2001;7: 1688-97.
13. Mander A. Haplotype analysis in population-based association studies. Stata J 2001;1:58-75.
14. Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001;29:233-7.
15. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-42.
16. Shin MS, Kim HS, Kang CS, Park WS, Kim SY, Lee SN, et al. Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 2002;99:4094-9.
17. Park WS, Lee JH, Shin MS, Park JY, Kim HS, Kim YS, et al. Inactivating mutations of the caspase-10 gene in gastric cancer. Oncogene 2002;21:2919-25.
18. Kim HS, Lee JW, Soung YH, Park WS, Kim SY, Lee JH, et al. Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 2003;125:708-15.
19. Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY, et al. Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma. Oncogene 2001;20:399-403.
20. Hazra A, Chamberlain RM, Grossman HB, Zhu Y, Spitz MR, Wu X. Death receptor 4 and bladder cancer risk. Cancer Res 2003;63: 1157-9.